tirzepatide pdufa date Retatrutide approval: FDA status, clinical trial results, and when it could be available FDA Grants Tirzepatide a New

medicine more sustainable. Why This GLP-1 Discount Matters GLP-1 medications like Wegovy and Zepbound have proven effective in helping patients manage diabetes and lose weight and may have additional health benefits, as well

Close observation helps manage adverse reactions swiftly and ensures the treatment remains effective

For patients with severe hypertriglyceridemia (500 mg/dL), dedicated triglyceride-lowering therapy and specialist referral should be considered regardless of tirzepatide use

Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products

If the effort falters, counter-regulation may happen, leading to episodes of overeating (see Figure 1)

Peter JV, Moran JL, Graham PL